Committed to regenerative medicine

Geistlich Pharma specializes in the regeneration of bone, cartilage and tissue. Geistlich’s regenerative medical devices aim to improve patients’ quality of life.

More than 600 employees worldwide work for Geistlich in the area of regenerative medicine. With its twelve affiliates and 60 distribution partners, Geistlich’s medical devices and medicinal products reach around 90 markets worldwide. The twelve affiliates cover the UK, Germany, Italy, France, China, Brazil, South Korea, North America, Australia, New Zealand, India and Japan.



Three business units under one Swiss roof

Geistlich Pharma is divided into three business units:

  • Geistlich Biomaterials: Dentistry, oral and maxillofacial surgery
  • Geistlich Surgery: Orthopedics, trauma surgery, sports medicine and spinal medicine
  • Geistlich Medical: Infectiology, advanced wound care and dermatology

The Swiss company, which has its headquarters in Wolhusen, central Switzerland, plus one other Swiss site, strives for Swiss Quality. All research and development as well as production take place at its headquarters in Wolhusen. The new build extension which opened in 2019 in Wolhusen reinforces the philosophic approach “Everything under one roof” and is further affirmation of the site. Bone and collagen have been manufactured here continuously since 1899.


“Our mission revolves around five core values – at the center of our culture is trust.”
Dr. Andreas Geistlich, President of the Administrative Board


The close collaboration with scientists and researchers plays a decisive role in the development of the products. Geistlich Pharma is organised into three business divisions: Geistlich Biomaterials (dental medicine), Geistlich Surgery (orthopaedics and traumatology) and Geistlich Medical (pharmaceuticals and supplementals). The company is entirely privately owned, enabling it to think and act with the long term in mind.


Dr. Mirjam Kessler
Director Corporate Communications